Wentao Yang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Skeletal Muscle

Laparoscopic Surgery

Transforming Growth Factor

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Liyuan Cui, Yumei Shen, Shanzhou Duan, Qifeng Ding, Yifei Wang, Wentao Yang, Yongbing Chen
GIMAP7 inhibits epithelial-mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway. Thoracic cancer 15 (4) (2023)
Liyuan Cui, Yumei Shen, Shanzhou Duan, Qifeng Ding, Yifei Wang, Wentao Yang, Yongbing Chen
GIMAP7 inhibits epithelial-mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway. Thoracic cancer (2023)
Liyuan Cui, Yumei Shen, Shanzhou Duan, Qifeng Ding, Yifei Wang, Wentao Yang, Yongbing Chen
GIMAP7 inhibits epithelial-mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway. Thoracic cancer 15 (4) (2023)
Liyuan Cui, Yumei Shen, Shanzhou Duan, Qifeng Ding, Yifei Wang, Wentao Yang, Yongbing Chen
GIMAP7 inhibits epithelial-mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway. Thoracic cancer 15 (4) (2023)
Liyuan Cui, Yumei Shen, Shanzhou Duan, Qifeng Ding, Yifei Wang, Wentao Yang, Yongbing Chen
GIMAP7 inhibits epithelial-mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway. Thoracic cancer 15 (4) (2023)
Xing Jin, Donglai Chen, Yumei Shen, Jian Shu, Yonghua Sang, Wentao Yang, Shanzhou Duan, Yongbing Chen
Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancer. Thoracic cancer 13 (19) (2022)